chrissv's picture
From chrissv rss RSS  subscribe Subscribe

Unichem-Laboratories-Pharmaceutical-Development-Company 

Unichem Laboratories is one of the leading pharmaceutical research and drug manufacturing companies in India with six manufacturing units across the country and its facilities have been accredited by international organizations.

 

 
 
Tags:  pharmaceutical  company  pharma  research  development 
Views:  270
Published:  October 29, 2010
 
0
download

Share plick with friends Share
save to favorite
Report Abuse Report Abuse
 
Related Plicks
Successful CPhI 2013 for Pharma Solutions

Successful CPhI 2013 for Pharma Solutions

From: piramalpharma
Views: 10 Comments: 0
In 2013, CPhI was held in Frankfurt from 22nd to 24th October. The show was a great success for Piramal Pharma Solutions, with hosting 3 days of meetings involving new and existing customers, Pharma Solutions hosted an on-stand wine tasting event by (more)

 
Contract Research Organizations

Contract Research Organizations

From: clinical
Views: 95 Comments: 0
http://www.clinicalresearchcompanies.com/
 
Admission in B.Pharma - PPT

Admission in B.Pharma - PPT

From: eee360india
Views: 91 Comments: 0
eshiksha.in is training distribution channel across India partner with various academic institutions of higher learning to deliver high quality relevant courses and certifications to improve the quality, delivery and outcome of education and thus in (more)

 
Launching a Pharmaceutical Brand in a Bad Economy Part 1- PharmaKinnex

Launching a Pharmaceutical Brand in a Bad Economy Part 1- PharmaKinnex

From: pharmakinnex
Views: 100 Comments: 0
Executing a successful pharmaceutical launch plan is a challenge even in the best of times. Unfortunately, these are not the best of times so the challenges for pharmaceutical marketers are exacerbated.
 
Advanced Anti Counterfeiting Solutions to Combat Spurious Drugs

Advanced Anti Counterfeiting Solutions to Combat Spurious Drugs

From: NewMomentum
Views: 81 Comments: 0
Pharmaceutical counterfeiting is an evolving and an ongoing threat to patients and pharmaceutical manufacturers and patients. Over the past few decades, various factors have contributed to the growth in counterfeit drugs.
 
European Pharma M2R - Preview

European Pharma M2R - Preview

From: we.CONECT
Views: 2 Comments: 0

 
Pharmaceutical-Indu stry-Executive-List s

Pharmaceutical-Industry-Executive-Lists

From: stevenparker
Views: 685 Comments: 0
Providing Highly Targeted, Precise & 100% Permission Based Pharmaceutical Industry Executives Lists

 
See all 
 
More from this user
No more plicks from this user
 
 
 URL:          AddThis Social Bookmark Button
Embed Thin Player: (fits in most blogs)
Embed Full Player :
 
 

Name

Email (will NOT be shown to other users)

 

 
 
Comments: (watch)
 
 
Notes:
 
Slide 1: PRESS RELEASE BSE: 506690 NSE: UNICHEMLAB Reuters: UNLB.BO Bloomberg: UN@IN Mumbai, September 23, 2010 Unichem Laboratories receives CEP for Alfuzosin Hydrochloride Unichem Laboratories Limited has been granted Certificate of suitability to European Pharmacopeia (CEP) by European Directorate for the Quality of Medicines and Healthcare (EDQM) for Alfuzosin Hydrochloride. The European Directorate for the Quality of Medicines & HealthCare is a Directorate of the Council of Europe located in Strasbourg. EDQM issues COS for APIs manufacturers to assure the APIs quality imported to EU. EDQM establishes and provides users with official standards for the manufacture and quality control of medicines applicable in all the signatory states of the Convention for the elaboration of a European Pharmacopoeia. It is responsible for setting up privileged collaboration with observer states at the European Pharmacopoeia Commission, and organizing a network of Official Medicines Control Laboratories to collaborate and share expertise. About Unichem Laboratories Limtied. Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives. The company has strong skills in product development, process chemistry and manufacturing of complex API as well as dosage forms. More information about the company can be found at www.unichemlabs.com. Contacts: Mr. M Gundu Rao Tel: +912266888380 Cell: +919820228944 l: gundurao@unichemlabs.com Mr. Rakesh Parikh Tel: +912266888414 Cell: +919892925555 : rparikh@unichemlabs.com Mr. K Subharaman Tel: +912266888404 Cell: +919833031121 : subharamank@unichemlabs.com This press release includes forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future events. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. Such factors include, but are not limited to, changes in local and global economic conditions, our ability to successfully implement our strategy, the market acceptance of and demand for our products, our growth and expansion, technological change and our exposure to market risks. By their nature, these expectations and projections are only estimates and could be materially different from actual results in the future. -o0o- Page 1 of 1

   
Time on Slide Time on Plick
Slides per Visit Slide Views Views by Location